i reckon next price sensitive ann will be update on the stem cell CoH trials -due anytime, some thought on SScene by end of Jan.
it's been underway long enough, and hasn't been shut down by FDA, so can't be a dangerous failure. CoH are advertising for more patients to take part. Might have been a couple of dud results.
also expect an ann on T Cell therapy IND filing and maybe even commencement of T Cell clinical trial (PI) before court & USPTO sorted.
and the ann that we will never see coming but always lurks is a buyout
- Forums
- ASX - By Stock
- BLT
- when back to 20c
when back to 20c, page-5
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)